Selectis Health Agrees to Acquisition by Black Pearl
Summary
Selectis Health has entered into an agreement to be acquired by Black Pearl. This development follows Black Pearl's termination of a tender offer for Selectis Health shares at $5.05 per share just last month. The agreement provides a potential resolution for the company, which has faced significant operational challenges, including a 30.5% revenue decline in Q1 2026 and persistent going concern issues noted in its 2025 annual report. This news offers a potential exit for shareholders and addresses the uncertainty surrounding the company's future. The specific terms of the acquisition, such as the price per share, will be crucial for investors.
At the time of this announcement, GBCS was trading at $3.20 on OTC in the Life Sciences sector, with a market capitalization of approximately $9.8M. The 52-week trading range was $0.41 to $6.25. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.